Chronic Migraine - The Basics

by Teri Robert Patient Advocate

Essentially, chronic migraine (CM) is migraines or tension-type headaches 15 or more days a month, which means that people with chronic migraine have a migraine or headache more often than not.

It should be stated here that a diagnosis of "chronic migraine" does not replace the more standard diagnosis of which form of migraine we have — migraine without aura, Migraine with aura, basilar-type migraine, etc. However, as research is conducted, medications are submitted to the FDA for approval for use in the treatment of migraine, and other issues arise, we're seeing that chronic forms of migraine often respond differently to treatment than episodic migraine, patient needs are different, and that there are many reasons to standardize criteria for classifying migraine as chronic.

As in other areas of medicine, when diagnosing and classifying types of migraine and other headache disorders, there is a "gold standard," a set of recognized criteria and classifications that are generally followed. This is helpful to patients as well as health care providers because the standardization keeps us all on the same page and, hopefully, understanding which form of migraine or headache we're discussing. Today, in the field of "headache medicine," the International Headache Society's (IHS) International Classification of Headache Disorders, 2nd Edition (ICHD-II), is considered the gold standard.

Chronic migraine was not addressed in the first edition of the ICHD, which was released in 1988. In 2004, chronic migraine appeared in the ICHD-II as a "complication of migraine." The description and criteria were brief. It was described as "migraine headache occurring on 15 or more days per month for more than three months in the absence of medication overuse." The criteria were simple. Chronic migraine had to have headache fulfilling the criteria for migraine without aura on 15 or more days per month for three months and could not be attributed to another disorder.1

Between ICHD-II and ICHD-II, Dr. Stephen Silberstein and Dr. Richard Lipton established criteria for what they called transformed migraine (TM). The described TM as "Daily or near-daily headache with migraine that begins with episodic migraines and as the headaches grow more frequent over months to years the associated symptoms become less severe and less frequent."4 (see Transformed Migraine - The Basics for more details.)

Finally, in 2006, the IHS revised the ICHD-II with this criteria for chronic Migraine:

Appendix 1.5.1 Chronic migraine2

A. Headache (tension-type and/or migraine) on 15 or more days per month for at least 3 months

B. Occurring in a patient who has had at least five attacks fulfilling criteria for 1.1 Migraine without aura

C. On 8 or more days per month for at least 3 months headache has fulfilled C1 and/or C2 below, that is, has fulfilled criteria for pain and associated symptoms of migraine without aura

C1. Has at least two of a-d

(a.) unilateral location
(b.) pulsating quality
(c.) moderate or severe pain intensity
(d.) aggravation by or causing avoidance of routine physical activity (e.g. walking or climbing stairs) and at least one of a or b
(e.) nausea and/or vomiting
(f.) photophobia and phonophobia

C2. Treated and relieved by triptan(s) or ergot before the expected development of C1 above

D. No medication overuse and not attributed to another causative disorder

Although it's not part of the ICHD-II, most of the current working definitions of chronic migraine also include that each headache or migraine last at least four hours if not treated. This has carried over into the definition of CM that the FDA uses in evaluating new drug applications for medications submitted to the FDA for the treatment of chronic migraine. At this time, the only medication that has FDA approval for the treatment of CM is onabotulinumtoxinA (Botox.)


Despite the confusion, it's safe to say that migraine is considered chronic when patients have 15 or more migraine or headache days per month. Following the ICHD-II, eight of those days must be days with migraine. To that, the FDA and some others add the requirement that the headache last at least four hours if not treated.

Patients who are diagnosed with CM should still know what form or forms of migraine they have — migraine with or without aura, basilar-type migraine, etc. Here's a listing of the types and subtypes of migraine from the ICHD-II:

1.1 Migraine without aura

1.2 Migraine with aura

1.2.1 Typical aura with migraine headache

1.2.2 Typical aura with non-migraine headache

1.2.3 Typical aura without headache

1.2.4 Familial hemiplegic migraine (FHM)

1.2.5 Sporadic hemiplegic migraine

1.2.6 Basilar-type migraine

1.3 Childhood periodic syndromes that are commonly precursors of migraine

1.3.1 Cyclical vomiting

1.3.2 Abdominal migraine

1.3.3 Benign paroxysmal vertigo of childhood

1.4 Retinal migraine

1.5 Complications of migraine

1.5.1 Chronic migraine

1.5.2 Status migrainosus

1.5.3 Persistent aura without infarction

1.5.4 Migrainous infarction

1.5.5 Migraine-triggered seizures

1.6 Probable migraine

1.6.1 Probable migraine without aura

1.6.2 Probable migraine with aura

1.6.5 Probable chronic migraine


1 Headache Classification Committee of the International Headache Society. "The International Classification of Headache Disorders, 2nd Edition." Cephalalgia 24 (s1). doi: 10.1111/j. 1468-2982.2003.00824.x

2 Headache Classification Committee of the International Headache Society. "Brief Report: New appendix criteria open for a broader concept of chronic migraine." Cephalalgia, 2006, 26, 742-746.

3 Headache Classification Committee of the International Headache Society. "Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain." Cephalalgia. 1988;8(Suppl. 7):1-96.

4 Manack, Aubrey, PhD; Turkel, Catherine, PharmD, PhD; Silberstein, Stephen, MD, FACP. "The Evolution of Chronic Migraine: Classification and Nomenclature." Headache 2009;49:1206-1213.

Medical review by John Claude Krusz, PhD, MD

Teri Robert
Meet Our Writer
Teri Robert

Teri Robert is a leading patient educator and advocate and the author of Living Well with Migraine Disease and Headaches. A co-founder of the Alliance for Headache Disorders Advocacy and the American Headache and Migraine Association, she received the National Headache Foundation's Patient Partners Award and a Distinguished Service Award from the American Headache Society.